Share

Luxembourg


  • 1-February-2023

    English

    EU Country Cancer Profile: Luxembourg 2023

    This profile identifies strengths, challenges and specific areas of action on cancer prevention and care in Luxembourg as part of the European Cancer Inequalities Registry, a flagship initiative of Europe’s Beating Cancer Plan. It provides a short synthesis of: the national cancer burden; risk factors for cancer (focusing on behavioural and environmental risk factors); early detection programmes; and cancer care performance (focusing on accessibility, care quality, costs and the impact of COVID-19 on cancer care).

  • 20-November-2022

    English

    Evaluation of Luxembourg's COVID-19 Response - Learning from the Crisis to Increase Resilience

    As countries seek to learn from the COVID-19 crisis and increase their resilience for the future, evaluations are important tools to understand what worked or not, why and for whom. This report is the first of its kind. It evaluates Luxembourg’s responses to the COVID-19 crisis in terms of risk preparedness, crisis management, as well as public health, education, economic and fiscal, and social and labour market policies. While Luxembourg’s response to the pandemic has been particularly agile, preserving the country’s resilience will require maintaining high levels of trust in government, reducing inequalities, and laying the foundations for inclusive growth. The findings and recommendations of this report will provide guidance to public authorities in these efforts.

  • 18-January-2022

    English

    Country Health Profiles 2021

    The State of Health in the EU’s Country Health Profiles provide a concise and policy-relevant overview of health and health systems in the EU/European Economic area, emphasizing the particular characteristics and challenges in each country. The 2021 edition has a special focus on the impact and responses of European health systems to the COVID-19 pandemic.

    Related Documents

  • 13-December-2021

    English

    Luxembourg: Country Health Profile 2021

    This profile provides a concise and policy-relevant overview of health and the health system in Luxembourg as part of the broader series of the State of Health in the EU country profiles. It provides a short synthesis of: the health status in the country; the determinants of health, focussing on behavioural risk factors; the organisation of the health system; and the effectiveness, accessibility and resilience of the health system. This edition has a special focus on the impact of COVID‑19. This profile is the joint work of the OECD and the European Observatory on Health Systems and Policies, in co-operation with the European Commission.

  • 28-November-2019

    English

    Luxembourg: Country Health Profile 2019

    This profile provides a concise and policy-relevant overview of health and the health system in Luxembourg as part of the broader series of the State of Health in the EU country profiles. It provides a short synthesis of: the health status in the country; the determinants of health, focussing on behavioural risk factors; the organisation of the health system; and the effectiveness, accessibility and resilience of the health system. This profile is the joint work of the OECD and the European Observatory on Health Systems and Policies, in co-operation with the European Commission.

  • 23-November-2017

    English

    Luxembourg: Country Health Profile 2017

    This report looks at the state of health in Luxembourg.

  • 28-March-2017

    English, PDF, 439kb

    Overview of Health Policy in Luxembourg

    The Luxembourg health care system achieves good results relatively efficiently. Luxembourg is, however, lagging behind other OECD countries with high volume of antibiotics prescribed and high rates of avoidable hospital admissions. Population ageing and increasing risk factors are other important challenges that demand further scrutiny.

    Related Documents

  • 2-August-2013

    English

    Public Health in an Age of Genomics

    This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.

    Related Documents

  • 7-February-2011

    English

    OECD Health Working Paper No. 55: Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues

    The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.

    Related Documents